Symbicort vs Xopenex
What to choose Symbicort or Xopenex
Symbicort is inhaler of type Control while Xopenex is of Rescue type. Symbicort and Xopenex are both brand inhalers. Symbicort is manufactured by pharmaceutical company AstraZeneca, while Xopenex is manufactured by Sunovion. The main substances of Symbicort are Budesonide and Formoterol. The available dosages for Symbicort are 100/6, 160/4.5, 200/6, 400/6. The main substance of Xopenex is Levalbuterol. The available dosage for Xopenex is 45 mcg.
The current cost for Symbicort is roughly $359 while average cost for Xopenex is approximately $256, said Greyson Smith, an Instructor at the Arizona State University East and a Medical Assistant at a clinic that uses Symbicort and Xopenex.
Symbicort and Xopenex Comparison
| Symbicort | Xopenex | |
|---|---|---|
| Type: | Control | Rescue |
| Manufacturer: | AstraZeneca | Sunovion |
| Substance: | Budesonide + Formoterol | Levalbuterol |
| Dosage: | 100/6, 160/4.5, 200/6, 400/6 | 45 mcg |
| Avg Price: | $359 | $256 |